Detection Study of Cardiovascular Risk in Toledo pharmacies (Spain)

被引:0
|
作者
Riolobos, Estrada G. [1 ,2 ]
Barrera, Peludo N. [3 ]
Alonso, Rodriguez A. [1 ,2 ]
Zorrilla, Martinez M. J. [4 ]
Dago, A. [5 ]
机构
[1] Colegio Farmaceuticos Toledo, Toledo, Spain
[2] SEFAC Castilla Mancha, Toledo, Spain
[3] Colegio Oficial Farmaceuticos Toledo, Adjunta Direcc Tecn, Toledo, Spain
[4] Colegio Oficial Farmaceuticos Toledo, Toledo, Spain
[5] Patrono Fdn Pharmaceut Care, Farmaceut Comunitaria, Madrid, Spain
来源
PHARMACEUTICAL CARE ESPANA | 2020年 / 22卷 / 02期
关键词
Community Pharmacy; Hypercholesterolemia; Diabetes; Hypertension; Cardiovascular Risk; Community Pharmacists; PREVENTION;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objetive: Determine the prevalence of CVR among people who visit pharmacies in the region of Toledo. Determine the capacity of pharmacies to assess CVR. Methods: It is carried out an observational cross-sectional study in which the CVR of the population of the region of Toledo that meets the inclusion criteria will be studied: Between 40 and 65 years old, with consent, cognitive state not impaired, be diagnosed and / or under treatment of any or only one of the following pathologies: HTA, DP or DMT2. Results: Pharmacies detected CVRF in more than half of the patients. In the CVR assessment, 3.9% (15) had high or very high RCV and 48.3% (183) had moderate CVR. Patients with a previous diagnosis of any of the chronic pathologies under study had a noncompliance with the therapeutic objective and / or altered levels of diagnostic values of pathologies that had not been diagnosed. This is the case of 61.5% (8) of patients on DMT2, 11.7% (9) of HTA patients and 8.8% (5) of DP patients who present high risk indicators. Conclusion: We conclude pharmacies have a real capacity to detect CVRF among people who come to them and they can also evaluate their CVR with reliability. We obtained correlation in the results with those of the WHO regarding the therapeutic failure and we proved the bad control of the population in general on pathologies related to the CVR.
引用
收藏
页码:54 / 74
页数:21
相关论文
共 50 条
  • [1] CARDIOVASCULAR RISK AND METABOLIC SYNDROME AT THE TOLEDO AREA STUDY
    Martinez Sesmero, J. M.
    Bastida, S.
    Sanchez-Muniz, F. J.
    NUTRICION HOSPITALARIA, 2009, 24 (02) : 167 - 175
  • [2] Detection of people at risk of diabetes in community pharmacies of Pontevedra (Spain) (DEDIPO)
    Antonio Fornos-Perez, Jose
    Floro Andres-Rodriguez, N.
    Carlos Andres-Iglesias, J.
    Luna-Cano, Reyes
    Garcia-Soidan, Javier
    Lorenzo-Veiga, Blanca
    Mera-Gallego, Rocio
    Garcia-Riestra, Rosario
    ENDOCRINOLOGIA Y NUTRICION, 2016, 63 (08): : 387 - 396
  • [3] Systematic screening for cardiovascular risk at pharmacies
    Rohla, Miklos
    Haberfeld, Heinz
    Sinzinger, Helmut
    Kritz, Harald
    Tscharre, Maximilian
    Freynhofer, Matthias K.
    Huber, Kurt
    Weiss, Thomas W.
    OPEN HEART, 2016, 3 (02):
  • [4] 'Toledo, Spain'
    Makuck, Peter
    SEWANEE REVIEW, 2007, 115 (03) : 338 - 339
  • [5] Diabetes and Cardiovascular Diseases Risk Assessment in Community Pharmacies: An Implementation Study
    Rondeaux, Sarah
    Braeckman, Tessa
    Beckwe, Mieke
    Biset, Natacha
    Maesschalck, Joris
    Duquet, Nathalie
    De Wulf, Isabelle
    Devroey, Dirk
    De Vriese, Carine
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (14)
  • [6] TOLEDO AREA STUDY: RELATIONSHIP BETWEEN PHYSICAL ACTIVITY AND CARDIOVASCULAR RISK FACTORS IN ADOLESCENTS
    Martinez-Sesmero, J. M.
    Guillen, T.
    Aragones, A.
    Bastida, S.
    Sanchez-Muniz, F. J.
    ANNALS OF NUTRITION AND METABOLISM, 2013, 63 : 969 - 969
  • [7] Feasibility of cardiovascular risk screening in Portuguese community pharmacies
    Fonseca, Anabela A.
    Lima, Tacio M.
    Castel-Branco, Margarida
    Figueiredo, Isabel, V
    PHARMACY PRACTICE-GRANADA, 2021, 19 (02):
  • [8] Cardiovascular risk screening program in Australian community pharmacies
    Peterson, Gregory M.
    Fitzmaurice, Kimbra D.
    Kruup, Helen
    Jackson, Shane L.
    Rasiah, Rohan L.
    PHARMACY WORLD & SCIENCE, 2010, 32 (03): : 373 - 380
  • [9] Cardiovascular risk screening program in Australian community pharmacies
    Gregory M. Peterson
    Kimbra D. Fitzmaurice
    Helen Kruup
    Shane L. Jackson
    Rohan L. Rasiah
    Pharmacy World & Science, 2010, 32 : 373 - 380
  • [10] Frailty Syndrome is a long-term mortality risk factor. Toledo Study in Aging, Spain
    Garcia, F.
    Castillo, C.
    Alfaro, A.
    Perez, A.
    De Lucas, A.
    De la Torre, M.
    Munoz, M.
    Larrion, J.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2010, 58 : 47 - 48